Concepedia
Statistics
Publications
6
Citations
315
H-Index
Active since
1997
Affiliations
Klinikum rechts der Isar(Current)
Wilex (Germany)
Ludwig-Maximilians-Universität München
Technical University of Munich
Max Planck Institute of Biochemistry
Markus Bürgle is an author at Klinikum rechts der Isar specializing in medicine, cell biology, and pathology.
Top concepts
MedicineCell BiologyPathologyImmunologyAutoimmunityInflammationPharmacologyImmune SystemTumor BiologyCell Signaling
Publications per year
1997–2002
The urokinase plasminogen activator system as a novel target for tumour therapy
Manfred Schmitt, Olaf G. Wilhelm, Ute Reuning et al. · Fibrinolysis & proteolysis/Fibrinolysis and proteolysis · 2000 · 108 citations
Drug Targeting, Novel Therapy, Tumour Therapy +11
Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides
Markus Bürgle, Marcus Koppitz, Christoph Riemer et al. · Biological Chemistry · 1997 · 65 citations
Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics
Niko Schmiedeberg, Manfred Schmitt, Christian Rölz et al. · Journal of Medicinal Chemistry · 2002 · 42 citations · Full text
A Novel Type of Bifunctional Inhibitor Directed against Proteolytic Activity and Receptor/Ligand Interaction
Bernd Muehlenweg, Irmgard Assfalg‐Machleidt, S.G. Parrado et al. · Journal of Biological Chemistry · 2000 · 39 citations · Full text
Cyclo19,31[D-Cys19]-uPA19-31 Is a Potent Competitive Antagonist of the Interaction of Urokinase-Type Plasminogen Activator with Its Receptor (CD87)
Viktor Magdolen, Markus Bürgle, Nuria Arroyo de Prada et al. · Biological Chemistry · 2001 · 32 citations
1–5 of 6